MX2021015936A - Metodos para preparar acido bempedoico y composiciones del mismo. - Google Patents
Metodos para preparar acido bempedoico y composiciones del mismo.Info
- Publication number
- MX2021015936A MX2021015936A MX2021015936A MX2021015936A MX2021015936A MX 2021015936 A MX2021015936 A MX 2021015936A MX 2021015936 A MX2021015936 A MX 2021015936A MX 2021015936 A MX2021015936 A MX 2021015936A MX 2021015936 A MX2021015936 A MX 2021015936A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- making
- same
- bempedoic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/04—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid halides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/285—Polyhydroxy dicarboxylic acids having five or more carbon atoms, e.g. saccharic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/307—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención proporciona métodos para preparar ácido 8-hidroxi-2,2,14,14-tetrametilpentadecanedioico y métodos para fabricar un material farmacéutico que comprende una cantidad purificada de ácido 8-hidroxi-2,2,14,14-tetrametilpentadecanodioic o. También se proporcionan composiciones y materiales farmacéuticos que incluyen una cantidad purificada de ácido 8-hidroxi-2,2,14,14-tetrametilpentadecanodioico así como métodos para tratar varias enfermedades y afecciones utilizando las composiciones y materiales farmacéuticos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962864873P | 2019-06-21 | 2019-06-21 | |
PCT/US2020/038622 WO2020257571A1 (en) | 2019-06-21 | 2020-06-19 | Methods of making bempedoic acid and compositions of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021015936A true MX2021015936A (es) | 2022-04-26 |
Family
ID=71528020
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021015936A MX2021015936A (es) | 2019-06-21 | 2020-06-19 | Metodos para preparar acido bempedoico y composiciones del mismo. |
MX2021015935A MX2021015935A (es) | 2019-06-21 | 2020-06-19 | Formas de sal de acido bempedoico y metodos para utilizar el mismo. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021015935A MX2021015935A (es) | 2019-06-21 | 2020-06-19 | Formas de sal de acido bempedoico y metodos para utilizar el mismo. |
Country Status (11)
Country | Link |
---|---|
US (8) | US20230141635A1 (es) |
EP (2) | EP3986860A1 (es) |
JP (2) | JP2022536979A (es) |
KR (2) | KR20220024816A (es) |
CN (3) | CN112437765A (es) |
AU (2) | AU2020296094A1 (es) |
BR (2) | BR112021025964A2 (es) |
CA (2) | CA3144371A1 (es) |
IL (2) | IL288909A (es) |
MX (2) | MX2021015936A (es) |
WO (2) | WO2020257573A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112021025964A2 (pt) | 2019-06-21 | 2022-05-24 | Esperion Therapeutics Inc | Formas de sal de ácido bempedoico e métodos para uso das mesmas |
WO2021064166A1 (en) | 2019-10-03 | 2021-04-08 | Synthon B.V. | Crystalline forms of bempedoic acid |
US20230036336A1 (en) * | 2019-12-06 | 2023-02-02 | Synthon B.V. | Crystalline forms of sodium salt of bempedoic acid |
CN111559961A (zh) * | 2020-05-26 | 2020-08-21 | 杭州科巢生物科技有限公司 | 一种贝派地酸晶型及其制备方法 |
WO2021255180A1 (en) * | 2020-06-19 | 2021-12-23 | Synthon B.V. | Salts of bempedoic acid |
CN112521282A (zh) * | 2020-12-02 | 2021-03-19 | 苏州汉德创宏生化科技有限公司 | 一种贝派地酸中间体及其合成方法 |
WO2022149161A1 (en) * | 2021-01-05 | 2022-07-14 | Dr. Reddy's Laboratories Limited | Process for preparation of bempedoic acid and its intermediates |
WO2022256378A1 (en) | 2021-06-02 | 2022-12-08 | Esperion Therapeutics, Inc. | Compositions containing and therapies using bempedoic acid and tolvaptan |
CN115504914B (zh) * | 2021-06-23 | 2024-05-07 | 武汉武药科技有限公司 | 一种贝派地酸中间体的制备方法 |
CN114436837B (zh) * | 2021-12-27 | 2024-02-20 | 甘李药业股份有限公司 | 一种贝派地酸中间体的纯化方法 |
WO2023187833A1 (en) * | 2022-03-30 | 2023-10-05 | Enaltec Labs Private Limited | A novel salt of bempedoic acid |
CN116589341A (zh) * | 2023-04-14 | 2023-08-15 | 苏州汉德创宏生化科技有限公司 | 一种抗高血酯药物中间体的制备方法 |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3152148A (en) | 1963-01-03 | 1964-10-06 | Dow Chemical Co | Preparation of comenic and pyromeconic acids |
US3441605A (en) | 1965-02-17 | 1969-04-29 | Wallace & Tiernan Inc | Diketo-dicarboxylic acids and salts and preparation thereof by alkaline oxidation |
GB1196598A (en) | 1966-12-21 | 1970-07-01 | Geigy Uk Ltd | Preparation of a Ketosebacic Acid |
GB1196594A (en) | 1966-12-21 | 1970-07-01 | Geigy Uk Ltd | Improvements in and relating to the production of Sebacic Acid |
GB1196597A (en) | 1966-12-21 | 1970-07-01 | Geigy Uk Ltd | Preparation of an Oxido-Cyclodecene |
GB1196596A (en) | 1966-12-21 | 1970-07-01 | Geigy Uk Ltd | Preparation of a hydroxysebacic acid |
GB1196595A (en) | 1966-12-21 | 1970-07-01 | Geigy Uk Ltd | Preparation of a Lactone |
FR1545224A (fr) | 1966-12-21 | 1968-11-08 | Geigy Ag J R | Procédé de préparation de l'acide sébacique |
US3773946A (en) | 1969-09-02 | 1973-11-20 | Parke Davis & Co | Triglyceride-lowering compositions and methods |
US3930024A (en) | 1969-09-02 | 1975-12-30 | Parke Davis & Co | Pharmaceutical compositions and methods |
JPS5522636A (en) | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
US4281200A (en) | 1979-08-30 | 1981-07-28 | The Dow Chemical Company | Catalytic process for converting oxazolidinones to their corresponding aminoalcohols |
JPS5639033A (en) | 1979-09-04 | 1981-04-14 | Kao Corp | Alpha-mono(methyl-branched alkyl glyceryl ether and skin cosmetic containing the same |
IL64542A0 (en) | 1981-12-15 | 1982-03-31 | Yissum Res Dev Co | Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
IT1164254B (it) | 1983-05-30 | 1987-04-08 | Luso Farmaco Inst | 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione |
JPS59232811A (ja) | 1983-06-16 | 1984-12-27 | Sumitomo Chem Co Ltd | 芳香族ポリアミドイミド樹脂成形体の製造方法 |
JPS60136512A (ja) | 1983-12-26 | 1985-07-20 | Eisai Co Ltd | 脂質代謝改善剤 |
DE3423166A1 (de) | 1984-06-22 | 1986-01-02 | Epis S.A., Zug | Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
US4896344A (en) | 1984-10-15 | 1990-01-23 | Grady John K | X-ray video system |
US4634119A (en) | 1985-07-11 | 1987-01-06 | Pesthy Paul K | Resilient exercise machine with body support platform |
US4714762A (en) | 1986-10-31 | 1987-12-22 | Warner-Lambert Company | Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof |
US5225439A (en) | 1987-01-28 | 1993-07-06 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti ulcers containing same |
US5166174A (en) | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
US5380709A (en) | 1987-01-28 | 1995-01-10 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti ulcers containing same |
US4758880A (en) | 1987-03-27 | 1988-07-19 | The Grass Valley Group, Inc. | Video matte generator |
JP2999579B2 (ja) | 1990-07-18 | 2000-01-17 | 武田薬品工業株式会社 | Dnaおよびその用途 |
US5254589A (en) | 1991-10-15 | 1993-10-19 | Warner-Lambert Company | Sulfonyl urea and carbamate ACAT inhibitors |
IL109431A (en) | 1993-05-14 | 2001-01-11 | Warner Lambert Co | Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds |
US5420339A (en) | 1993-11-22 | 1995-05-30 | Warner-Lambert Company | Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors |
JP2937012B2 (ja) | 1994-04-08 | 1999-08-23 | 時久 増田 | 角筒包装袋の製造方法及び装置 |
US5504073A (en) | 1994-07-01 | 1996-04-02 | Warner-Lambert Company | PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
US5578639A (en) | 1994-07-01 | 1996-11-26 | Warner-Lambert Company | PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
SE9500778D0 (sv) | 1995-03-03 | 1995-03-03 | Pharmacia Ab | Process for producing a protein |
US5648387A (en) | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
PL186714B1 (pl) | 1995-11-02 | 2004-02-27 | Warner Lambert Co | Kompozycja farmaceutyczna do regulowania stężenialipidów do ssaka |
US5807846A (en) | 1996-11-14 | 1998-09-15 | Warner-Lambert Company | Phosphonamide ACAT inhibitors |
IL119971A (en) | 1997-01-07 | 2003-02-12 | Yissum Res Dev Co | Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids |
US6093744A (en) | 1997-04-21 | 2000-07-25 | Warner-Lambert Company | N-acyl sulfamic acid esters useful as hypocholesterolemic agents |
IL121165A0 (en) | 1997-06-26 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical compositions containing carboxylic acids and derivatives thereof |
US6037323A (en) | 1997-09-29 | 2000-03-14 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6004925A (en) | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
NZ503598A (en) | 1997-11-25 | 2002-06-28 | Warner Lambert Co | Hydroxylated gemfibrozil, atorvastatin and fluvastatin with antioxidant activity for inhibition of lipoprotein oxidation |
EP1204626B1 (en) | 1999-04-01 | 2008-01-16 | Esperion Therapeutics Inc. | Ether compounds, compositions, and uses thereof |
JP2004532799A (ja) | 2000-10-11 | 2004-10-28 | エスペリオン セラピューティクス,インコーポレイテッド | コレステロール管理および関連用途のためのスルフィド化合物およびジスルフィド化合物ならびにそれらを含む組成物 |
US7304093B2 (en) | 2000-10-11 | 2007-12-04 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
CA2425311C (en) | 2000-10-11 | 2011-06-14 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
AU2002213137A1 (en) | 2000-10-11 | 2002-04-22 | Esperion Therapeutics, Inc. | Ether compounds and compositions for cholesterol management and related uses |
CA2425678A1 (en) | 2000-10-11 | 2002-04-18 | Jean-Louis H. Dasseux | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
US7053046B2 (en) | 2001-12-21 | 2006-05-30 | Mcgrath Kevin | Peptide activators of VEGF |
MX349134B (es) | 2003-01-23 | 2017-07-12 | Esperion Therapeutics Inc | Compuestos de hidroxilo y composiciones para el manejo del colesterol y usos relacionados. |
WO2005068412A1 (en) | 2003-12-24 | 2005-07-28 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
JP4553181B2 (ja) | 2004-03-25 | 2010-09-29 | 株式会社サタケ | 残留農薬分析方法 |
US8209479B2 (en) | 2007-07-18 | 2012-06-26 | Google Inc. | Memory circuit system and method |
EP2800564B1 (en) | 2012-01-06 | 2020-05-06 | NeuroBo Pharmaceuticals, Inc. | Compound for use in methods of reducing risk of cardiovascular disease |
US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
US20160058751A1 (en) | 2013-03-28 | 2016-03-03 | Cellworks Group, Inc. | Composition and method for treating cancer |
WO2015018060A1 (en) * | 2013-08-09 | 2015-02-12 | Agios Pharmaceuticals, Inc. | Crystalline forms of therapeutically active compounds and use thereof |
EP3267989A4 (en) | 2015-03-13 | 2018-11-07 | Esperion Therapeutics, Inc. | Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease |
MA41793A (fr) | 2015-03-16 | 2018-01-23 | Esperion Therapeutics Inc | Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire |
WO2017023165A1 (en) | 2015-08-04 | 2017-02-09 | Dezima Pharma B.V. | Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and an atp citrate lyase inhibitor – ampk activator |
EP3579827A4 (en) | 2017-02-08 | 2021-01-06 | Esperion Therapeutics, Inc. | TRIPLET COMBINATION FORMULATIONS AND METHODS FOR TREATING OR REDUCING THE RISK OF CARDIAC DISORDERS |
US20180338922A1 (en) * | 2017-05-26 | 2018-11-29 | Esperion Therapeutics, Inc. | Fixed dose formulations |
CN107628975B (zh) * | 2017-09-17 | 2019-10-29 | 贵州医科大学 | 赖氨酸衍生物类组蛋白去乙酰化酶抑制剂及其合成和应用 |
CN109721486A (zh) * | 2017-10-31 | 2019-05-07 | 鲁南制药集团股份有限公司 | 一种8-羟基-2,2,14,14-四甲基-十五烷二酸的合成方法 |
KR20200123181A (ko) | 2018-02-16 | 2020-10-28 | 에스페리온 테라피유틱스 인코포레이티드 | 뱀페도익산의 지속 방출형 제제 |
EP3666750A1 (en) * | 2018-12-10 | 2020-06-17 | Sandoz AG | Crystalline form of bempedoic acid |
CN113227061A (zh) * | 2018-12-31 | 2021-08-06 | 印度鲁宾有限公司 | 贝派地酸的新盐和多晶型物 |
BR112021025964A2 (pt) | 2019-06-21 | 2022-05-24 | Esperion Therapeutics Inc | Formas de sal de ácido bempedoico e métodos para uso das mesmas |
US20230036336A1 (en) | 2019-12-06 | 2023-02-02 | Synthon B.V. | Crystalline forms of sodium salt of bempedoic acid |
WO2022149161A1 (en) | 2021-01-05 | 2022-07-14 | Dr. Reddy's Laboratories Limited | Process for preparation of bempedoic acid and its intermediates |
-
2020
- 2020-06-19 BR BR112021025964A patent/BR112021025964A2/pt unknown
- 2020-06-19 MX MX2021015936A patent/MX2021015936A/es unknown
- 2020-06-19 CN CN202080003148.4A patent/CN112437765A/zh active Pending
- 2020-06-19 JP JP2021575994A patent/JP2022536979A/ja not_active Withdrawn
- 2020-06-19 CN CN202080003150.1A patent/CN112437766A/zh active Pending
- 2020-06-19 BR BR112021025928A patent/BR112021025928A2/pt unknown
- 2020-06-19 WO PCT/US2020/038624 patent/WO2020257573A1/en active Application Filing
- 2020-06-19 AU AU2020296094A patent/AU2020296094A1/en active Pending
- 2020-06-19 WO PCT/US2020/038622 patent/WO2020257571A1/en active Application Filing
- 2020-06-19 CA CA3144371A patent/CA3144371A1/en active Pending
- 2020-06-19 KR KR1020227002108A patent/KR20220024816A/ko unknown
- 2020-06-19 MX MX2021015935A patent/MX2021015935A/es unknown
- 2020-06-19 EP EP20737751.6A patent/EP3986860A1/en not_active Withdrawn
- 2020-06-19 US US17/620,885 patent/US20230141635A1/en active Pending
- 2020-06-19 KR KR1020227002107A patent/KR20220024815A/ko not_active Application Discontinuation
- 2020-06-19 CN CN202211022415.XA patent/CN115429784A/zh active Pending
- 2020-06-19 EP EP20737750.8A patent/EP3986859A1/en active Pending
- 2020-06-19 AU AU2020295503A patent/AU2020295503A1/en not_active Abandoned
- 2020-06-19 CA CA3144372A patent/CA3144372A1/en active Pending
- 2020-06-19 JP JP2021575993A patent/JP2022537049A/ja active Pending
-
2021
- 2021-01-15 US US17/150,325 patent/US11407705B2/en active Active
- 2021-01-15 US US17/150,321 patent/US20210139405A1/en not_active Abandoned
- 2021-12-12 IL IL288909A patent/IL288909A/en unknown
- 2021-12-14 IL IL288997A patent/IL288997A/en unknown
-
2022
- 2022-01-18 US US17/577,829 patent/US11760714B2/en active Active
- 2022-05-12 US US17/742,728 patent/US11613511B2/en active Active
- 2022-07-19 US US17/867,744 patent/US11987548B2/en active Active
-
2023
- 2023-04-10 US US18/297,846 patent/US11926584B2/en active Active
- 2023-08-16 US US18/450,591 patent/US20240182396A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021015936A (es) | Metodos para preparar acido bempedoico y composiciones del mismo. | |
MX2021009246A (es) | Inmunomoduladores, composiciones y metodos de los mismos. | |
MX2020010999A (es) | Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos. | |
PH12020551043A1 (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
CR20220215A (es) | Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1 | |
MX2020009062A (es) | Piperidinil-3-(ariloxi)propanamidas y propanoatos. | |
MX2022003102A (es) | Degradadores bifuncionales de brd9 y sus metodos de uso. | |
CR20220216A (es) | Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1 | |
TN2017000168A1 (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
MX2019012847A (es) | Compuestos de c5-anilinoquinazolina y su uso en el tratamiento del cancer. | |
MX2020012058A (es) | Compuestos de triazolopirimidina y su uso en el tratamiento del cancer. | |
WO2018183631A8 (en) | Novel pharmaceutical formulations containing indirubin and derivatives thereof and methods of making and using the same | |
MX2021004566A (es) | Compuestos terapeuticos. | |
WO2019224790A3 (en) | Prodrugs of fulvestrant | |
CR20220160A (es) | Derivados de piridazin-3(2h)-ona fusionados con azol | |
MX2021011723A (es) | Ligandos de pseudocinasa tyk2. | |
MX2021009555A (es) | Ligandos de pseudocinasa tyk2. | |
MX2023010711A (es) | Fenalquilaminas y métodos de preparación y uso de las mismas. | |
MX2021012491A (es) | Agentes antiproliferativos para el tratamiento de la hipertensión arterial pulmonar. | |
MX2020012281A (es) | Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas. | |
MX2022005563A (es) | Ligandos de la pseudoquinasa tyk2. | |
MX2023003230A (es) | Procesos e intermediario para la preparacion a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbon il)-piridin-2-il]-benzamida y preparacion de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il ]-benzamida. | |
GB201907558D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
WO2019200314A3 (en) | Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof | |
SG10201907291QA (en) | Monomethylfumarate prodrug compositions |